These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1651423)
1. Human papillomavirus type 18 E6*, E6, and E7 protein synthesis in cell-free translation systems and comparison of E6 and E7 in vitro translation products to proteins immunoprecipitated from human epithelial cells. Roggenbuck B; Larsen PM; Fey SJ; Bartsch D; Gissmann L; Schwarz E J Virol; 1991 Sep; 65(9):5068-72. PubMed ID: 1651423 [TBL] [Abstract][Full Text] [Related]
2. Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. Stacey SN; Jordan D; Snijders PJ; Mackett M; Walboomers JM; Arrand JR J Virol; 1995 Nov; 69(11):7023-31. PubMed ID: 7474122 [TBL] [Abstract][Full Text] [Related]
3. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. Tang S; Tao M; McCoy JP; Zheng ZM J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. Tan TM; Gloss B; Bernard HU; Ting RC J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. Park DS; Selvey LA; Kelsall SR; Frazer IH J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603 [TBL] [Abstract][Full Text] [Related]
6. The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53. Shally M; Alloul N; Jackman A; Muller M; Gissmann L; Sherman L Virus Res; 1996 Jun; 42(1-2):81-96. PubMed ID: 8806176 [TBL] [Abstract][Full Text] [Related]
7. HPV18 Utilizes Two Alternative Branch Sites for E6*I Splicing to Produce E7 Protein. Brant AC; Majerciak V; Moreira MAM; Zheng ZM Virol Sin; 2019 Apr; 34(2):211-221. PubMed ID: 30945125 [TBL] [Abstract][Full Text] [Related]
8. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. Stacey SN; Jordan D; Williamson AJ; Brown M; Coote JH; Arrand JR J Virol; 2000 Aug; 74(16):7284-97. PubMed ID: 10906182 [TBL] [Abstract][Full Text] [Related]
9. Biologic activity of human papillomavirus type 16 E6/E7 cDNA clones isolated from SiHa cervical carcinoma cell line. Yamada T; Yamashita T; Nishikawa T; Fujimoto S; Fujinaga K Virus Genes; 1995; 10(1):15-25. PubMed ID: 7483285 [TBL] [Abstract][Full Text] [Related]
10. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. Hoppe-Seyler F; Butz K Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181 [TBL] [Abstract][Full Text] [Related]
11. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. Sedman SA; Barbosa MS; Vass WC; Hubbert NL; Haas JA; Lowy DR; Schiller JT J Virol; 1991 Sep; 65(9):4860-6. PubMed ID: 1651408 [TBL] [Abstract][Full Text] [Related]
12. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78. Ajiro M; Zheng ZM mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589 [TBL] [Abstract][Full Text] [Related]
13. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087 [TBL] [Abstract][Full Text] [Related]
16. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419 [TBL] [Abstract][Full Text] [Related]
17. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
18. The E2 protein of human papillomavirus type 16 is translated from a variety of differentially spliced polycistronic mRNAs. Alloul N; Sherman L J Gen Virol; 1999 Jan; 80 ( Pt 1)():29-37. PubMed ID: 9934680 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010 [TBL] [Abstract][Full Text] [Related]
20. A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA. Glahder JA; Hansen CN; Vinther J; Madsen BS; Norrild B J Gen Virol; 2003 Dec; 84(Pt 12):3429-3441. PubMed ID: 14645924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]